Baudax Bio Insiders
BXRXDelisted Stock | USD 0.76 0.06 7.32% |
Baudax Bio employs about 9 people. The company is managed by 6 executives with a total tenure of roughly 21 years, averaging almost 3.0 years of service per executive, having 1.5 employees per reported executive. Break down of Baudax Bio's management performance can provide insight into the company performance.
Baudax |
Baudax Bio Management Team Effectiveness
The company has return on total asset (ROA) of (1.1493) % which means that it has lost $1.1493 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (47.0421) %, meaning that it created substantial loss on money invested by shareholders. Baudax Bio's management efficiency ratios could be used to measure how well Baudax Bio manages its routine affairs as well as how well it operates its assets and liabilities.Baudax Bio Workforce Comparison
Baudax Bio is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 941. Baudax Bio maintains roughly 9.0 in number of employees contributing less than 1% to equities under Health Care industry.
Baudax Bio Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Baudax Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Baudax Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Baudax Bio insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Lake Ryan David over six months ago Disposition of 15064 shares by Lake Ryan David of Baudax BioInc at 1.14 subject to Rule 16b-3 | ||
Kim Yong Chan over six months ago Disposition of tradable shares by Kim Yong Chan of Baudax BioInc subject to Rule 16b-3 | ||
Altomari Alfred over six months ago Insider Trading | ||
Kim Yong Chan over a year ago Baudax BioInc exotic insider transaction detected |
Baudax Bio Notable Stakeholders
A Baudax Bio stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Baudax Bio often face trade-offs trying to please all of them. Baudax Bio's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Baudax Bio's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Geraldine Henwood | CEO President | Profile | |
Chan Yong | Chief Director | Profile | |
Natalie McAndrew | Consultant Officer | Profile | |
Jillian Dilmore | Corp Controller | Profile | |
Diane Myers | VP Quality | Profile | |
Mike Choi | Vice Analysis | Profile |
About Baudax Bio Management Performance
The success or failure of an entity such as Baudax Bio often depends on how effective the management is. Baudax Bio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Baudax management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Baudax management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company was incorporated in 2019 and is based in Malvern, Pennsylvania. Baudax Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 80 people.
Please note, the imprecision that can be found in Baudax Bio's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Baudax Bio. Check Baudax Bio's Beneish M Score to see the likelihood of Baudax Bio's management manipulating its earnings.
Baudax Bio Workforce Analysis
Traditionally, organizations such as Baudax Bio use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Baudax Bio within its industry.Baudax Bio Manpower Efficiency
Return on Baudax Bio Manpower
Revenue Per Employee | 141K | |
Revenue Per Executive | 211.5K | |
Net Loss Per Employee | 794.9K | |
Net Loss Per Executive | 1.2M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Baudax Stock
If you are still planning to invest in Baudax Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Baudax Bio's history and understand the potential risks before investing.
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |